Torrent Pharmaceuticals Ltd. — documents
165 files on disk. SHA-256 from the acquisition manifests; links open the exchange copy.
| Class | Period | Scope / kind | Filing date | File | SHA-256 |
|---|---|---|---|---|---|
| Results XBRL (NSE) | 2018-03-31 | Standalone | — | INDAS_36450_13605_31052018120534_WEB.xml | 328c9a5838d52406 |
| Results XBRL (NSE) | 2018-03-31 | Consolidated | — | INDAS_36451_13609_31052018121127_WEB.xml | 64123584ad21ff8f |
| Results XBRL (NSE) | 2018-06-30 | Standalone | — | INDAS_37808_31512_02082018081234_WEB.xml | 3e11988935429445 |
| Results XBRL (NSE) | 2018-06-30 | Consolidated | — | INDAS_37809_31514_02082018081427_WEB.xml | 608322330f3a0c01 |
| Results XBRL (NSE) | 2018-09-30 | Standalone | — | INDAS_40229_57782_03112018055632_WEB.xml | d576ef81923ed3ef |
| Results XBRL (NSE) | 2018-09-30 | Consolidated | — | INDAS_40233_57787_03112018060059_WEB.xml | 1736db2fca4198ba |
| Results XBRL (NSE) | 2018-12-31 | Standalone | — | INDAS_41923_78753_30012019062752_WEB.xml | 41067e73e1abe98b |
| Results XBRL (NSE) | 2018-12-31 | Consolidated | — | INDAS_41924_78756_30012019063011_WEB.xml | 9b4861b89f3ad26b |
| Results XBRL (NSE) | 2019-03-31 | Standalone | — | INDAS_44435_103110_20052019083553_WEB.xm | 1a012ee4048ce10b |
| Results XBRL (NSE) | 2019-03-31 | Consolidated | — | INDAS_44436_103113_20052019083821_WEB.xm | 754c38dd3f8c1aff |
| Results XBRL (NSE) | 2019-06-30 | Standalone | — | INDAS_46132_124216_23072019075039_WEB.xm | aeb2c0c08adad022 |
| Results XBRL (NSE) | 2019-06-30 | Consolidated | — | INDAS_46133_124221_23072019075413_WEB.xm | cbcb58447f235574 |
| Results XBRL (NSE) | 2019-09-30 | Standalone | — | INDAS_48818_157230_23102019063311_WEB.xm | ed39f9e3aced6496 |
| Results XBRL (NSE) | 2019-09-30 | Consolidated | — | INDAS_48820_157239_23102019063959_WEB.xm | 3df1f6e9c34d9005 |
| Results XBRL (NSE) | 2019-12-31 | Standalone | — | INDAS_51767_211408_27012020064556_WEB.xm | c5fb74e69192b5ce |
| Results XBRL (NSE) | 2019-12-31 | Consolidated | — | INDAS_51770_211416_27012020064852_WEB.xm | 49ff9faa0fd8fd6e |
| Results XBRL (NSE) | 2020-03-31 | Standalone | — | INDAS_55384_261335_27052020010858_WEB.xm | 13ab27f1a1f2bad5 |
| Results XBRL (NSE) | 2020-03-31 | Consolidated | — | INDAS_55386_261344_27052020011420_WEB.xm | 7cec5b524d2d7b1d |
| Results XBRL (NSE) | 2020-06-30 | Consolidated | — | INDAS_58718_299889_30072020081123_WEB.xm | 1a2f3e3b27b3c4fe |
| Results XBRL (NSE) | 2020-06-30 | Standalone | — | INDAS_58723_299904_30072020081913_WEB.xm | b13b459dedc9009c |
| Results XBRL (NSE) | 2020-09-30 | Standalone | — | INDAS_62409_350679_26102020053550_WEB.xm | 3f7f6a4d95fcfecc |
| Results XBRL (NSE) | 2020-09-30 | Consolidated | — | INDAS_62410_350682_26102020053813_WEB.xm | 38b0add84c4115e4 |
| Results XBRL (NSE) | 2020-12-31 | Standalone | — | INDAS_67411_403735_08022021062822_WEB.xm | 94155c0fe2f36f94 |
| Results XBRL (NSE) | 2020-12-31 | Consolidated | — | INDAS_67413_403744_08022021063150_WEB.xm | 38b2925d9a430572 |
| Results XBRL (NSE) | 2021-03-31 | Standalone | — | INDAS_70082_448724_18052021053021_WEB.xm | aacb2eafdc787d99 |
| Results XBRL (NSE) | 2021-03-31 | Consolidated | — | INDAS_70083_448729_18052021053250_WEB.xm | 9aa71780b2c1a91c |
| Results XBRL (NSE) | 2021-06-30 | Standalone | — | INDAS_73445_496107_27072021061351_WEB.xm | 39c6988fcc7f07d5 |
| Results XBRL (NSE) | 2021-06-30 | Consolidated | — | INDAS_73446_496113_27072021061908_WEB.xm | f1b0572b5972e71e |
| Results XBRL (NSE) | 2021-09-30 | Standalone | — | INDAS_76800_546539_27102021113029_WEB.xm | d026ac3b8fc0332c |
| Results XBRL (NSE) | 2021-09-30 | Consolidated | — | INDAS_76802_546545_27102021113315_WEB.xm | 3549911a0ffcee42 |
| Results XBRL (NSE) | 2021-12-31 | Standalone | — | INDAS_80482_598887_25012022065145_WEB.xm | cc446684b6512914 |
| Results XBRL (NSE) | 2021-12-31 | Consolidated | — | INDAS_80483_598893_25012022065727_WEB.xm | a35c6dc9d7f8b576 |
| Results XBRL (NSE) | 2022-03-31 | Standalone | — | INDAS_85434_660883_25052022080020_WEB.xm | d263637fd1cf2e94 |
| Results XBRL (NSE) | 2022-03-31 | Consolidated | — | INDAS_85437_660893_25052022080444_WEB.xm | 37e33d304468b824 |
| Results XBRL (NSE) | 2022-06-30 | Standalone | — | INDAS_615582_2373_29072022194942_WEB.xml | 320a7ab6c7e2887b |
| Results XBRL (NSE) | 2022-09-30 | Standalone | — | INDAS_788975_4714_21102022201022_WEB.xml | 21b4aeced088b15e |
| Results XBRL (NSE) | 2022-09-30 | Consolidated | — | INDAS_788976_4714_21102022201022_WEB.xml | b4ed0ad1c7e20b60 |
| Results XBRL (NSE) | 2022-12-31 | Standalone | — | INDAS_87902_779071_25012023060525_WEB.xm | 8758132ba3149699 |
| Results XBRL (NSE) | 2022-12-31 | Consolidated | — | INDAS_87905_779080_25012023061111_WEB.xm | 650929b70e8a6fa2 |
| Results XBRL (NSE) | 2023-03-31 | Standalone | — | INDAS_93671_858869_30052023073339.xml | c8da495ac97e3a67 |
| Results XBRL (NSE) | 2023-03-31 | Consolidated | — | INDAS_93674_858897_30052023073710.xml | 6c050868e71cf78a |
| Results XBRL (NSE) | 2023-06-30 | Standalone | — | INDAS_95569_910185_07082023060000.xml | 4d123b035b4b7690 |
| Results XBRL (NSE) | 2023-06-30 | Consolidated | — | INDAS_95573_910217_07082023060640.xml | 4c4084d6f3c1812c |
| Results XBRL (NSE) | 2023-09-30 | Standalone | — | INDAS_97877_966817_25102023121030.xml | 5eca91bf77ca391a |
| Results XBRL (NSE) | 2023-09-30 | Consolidated | — | INDAS_97878_966826_25102023121318.xml | d7ce42cc13e5d251 |
| Results XBRL (NSE) | 2023-12-31 | Standalone | — | INDAS_102098_1042620_02022024033213.xml | 946051396f6b3ad1 |
| Results XBRL (NSE) | 2023-12-31 | Consolidated | — | INDAS_102099_1042629_02022024033554.xml | 15a8b110d71ae20c |
| Results XBRL (NSE) | 2024-03-31 | Standalone | — | INDAS_107098_1138033_24052024070219.xml | 02f660609a20e6e8 |
| Results XBRL (NSE) | 2024-03-31 | Consolidated | — | INDAS_107101_1138062_24052024070903.xml | d21862dfaad5e211 |
| Results XBRL (NSE) | 2024-06-30 | Standalone | — | INDAS_109318_1200410_23072024062337.xml | 619d8377f9bd14ed |
| Results XBRL (NSE) | 2024-06-30 | Consolidated | — | INDAS_109319_1200426_23072024063102.xml | 33b954fd83257935 |
| Results XBRL (NSE) | 2024-09-30 | Standalone | — | INDAS_113370_1288753_25102024054524.xml | defc9a9343a83bb0 |
| Results XBRL (NSE) | 2024-09-30 | Consolidated | — | INDAS_113372_1288764_25102024054827.xml | 86256e624747dcc1 |
| Results XBRL (NSE) | 2024-12-31 | Standalone | — | INDAS_117638_1360530_24012025053059.xml | 9bb717969bb6afb6 |
| Results XBRL (NSE) | 2024-12-31 | Consolidated | — | INDAS_117639_1360534_24012025053307.xml | f8b0306c500cfb08 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1444801_20052025 | 0aa919df957d8d38 |
| Results XBRL (NSE) | 2025-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1444809_20052025 | a9e7944a4b7623c7 |
| Results XBRL (NSE) | 2025-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1445419_21052025 | 39fb3e0f3997874a |
| Results XBRL (NSE) | 2025-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1495337_28072025 | b990c89499a8fcb1 |
| Results XBRL (NSE) | 2025-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1495351_28072025 | 184b9bbe4ecd8c85 |
| Results XBRL (NSE) | 2025-09-30 | Standalone | — | INTEGRATED_FILING_INDAS_1568466_07112025 | 18a8068f723997e6 |
| Results XBRL (NSE) | 2025-09-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1568469_07112025 | 31653aac5b269cda |
| Results XBRL (NSE) | 2025-12-31 | Standalone | — | INTEGRATED_FILING_INDAS_1625484_13022026 | 2c4b07fa9368473f |
| Results XBRL (NSE) | 2025-12-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1625487_13022026 | ac613af2869f4c75 |
| Results XBRL (NSE) | 2026-03-31 | Consolidated | — | INTEGRATED_FILING_INDAS_1671721_22052026 | d326b3e8b1902472 |
| Results XBRL (NSE) | 2026-03-31 | Standalone | — | INTEGRATED_FILING_INDAS_1671920_23052026 | 223e5fb42316dd42 |
| Results XBRL (NSE) | 2026-06-30 | Consolidated | — | INTEGRATED_FILING_INDAS_1705312_30072026 | ed170cbf91ff9e7b |
| Results XBRL (NSE) | 2026-06-30 | Standalone | — | INTEGRATED_FILING_INDAS_1705313_30072026 | ed39d5d9108a030c |
| Results XBRL (BSE) | 2018-06-30 | Standalone | 2018-08-02T20:06:23 | Main_Ind_As_500420_28201820613.xml | 04a498e704182039 |
| Results XBRL (BSE) | 2018-06-30 | Consolidated | 2018-08-02T20:06:23 | Main_Ind_As_500420_2820182074.xml | 16ef67ebc4b3f01e |
| Results XBRL (BSE) | 2018-09-30 | Consolidated | 2018-11-03T17:46:46 | Main_Ind_As_500420_3112018174527.xml | 2ae64a15a90869d9 |
| Results XBRL (BSE) | 2018-09-30 | Standalone | 2018-11-04T17:22:02 | Main_Ind_As_500420_3112018174630.xml | 9921ee85d361a6e3 |
| Results XBRL (BSE) | 2018-12-31 | Standalone | 2019-01-30T18:15:12 | Main_Ind_As_500420_3012019181454.xml | 463e0838b7b0e169 |
| Results XBRL (BSE) | 2018-12-31 | Consolidated | 2019-01-30T18:15:12 | Main_Ind_As_500420_301201918183.xml | 2dbb55699aee0507 |
| Results XBRL (BSE) | 2019-03-31 | Standalone | 2019-05-20T20:27:11 | Main_Ind_As_500420_2052019202654.xml | 8dadbbe9df97fd91 |
| Results XBRL (BSE) | 2019-03-31 | Consolidated | 2019-05-20T20:27:11 | Main_Ind_As_500420_2052019202747.xml | 67ac5726841e2c98 |
| Results XBRL (BSE) | 2019-06-30 | Standalone | 2019-07-23T19:33:12 | Main_Ind_As_500420_237201919332.xml | e163a21430ee3ed8 |
| Results XBRL (BSE) | 2019-06-30 | Consolidated | 2019-07-23T19:33:12 | Main_Ind_As_500420_2372019193448.xml | 81ba344314756c9f |
| Results XBRL (BSE) | 2019-09-30 | Standalone | 2019-10-23T18:31:58 | Main_Ind_As_500420_23102019183140.xml | d4c2a7ed6676fc64 |
| Results XBRL (BSE) | 2019-09-30 | Consolidated | 2019-10-23T18:31:57 | Main_Ind_As_500420_23102019183656.xml | 735fa8a1f38e9748 |
| Results XBRL (BSE) | 2019-12-31 | Consolidated | 2020-01-27T18:23:55 | Main_Ind_As_500420_2712020182011.xml | 9d8b6a9c4f888423 |
| Results XBRL (BSE) | 2019-12-31 | Standalone | 2020-01-27T18:23:55 | Main_Ind_As_500420_2712020182340.xml | 2ee4cf29ae3be3f9 |
| Results XBRL (BSE) | 2020-03-31 | Standalone | 2020-05-27T12:58:32 | Main_Ind_As_500420_275202012589.xml | 2b65f4970fe0a8b7 |
| Results XBRL (BSE) | 2020-03-31 | Consolidated | 2020-05-27T12:58:32 | Main_Ind_As_500420_275202013025.xml | 83b929b16fd45e52 |
| Results XBRL (BSE) | 2020-06-30 | Consolidated | 2020-07-30T20:04:26 | Main_Ind_As_500420_307202020312.xml | 070301d5500fa7e1 |
| Results XBRL (BSE) | 2020-06-30 | Standalone | 2020-07-30T20:04:26 | Main_Ind_As_500420_307202020415.xml | aba06418c41a4ae8 |
| Results XBRL (BSE) | 2020-09-30 | Standalone | 2020-10-26T17:45:14 | Main_Ind_As_500420_26102020174439.xml | 240d5bd9d79a8473 |
| Results XBRL (BSE) | 2020-09-30 | Consolidated | 2020-10-26T17:45:14 | Main_Ind_As_500420_26102020174549.xml | 040af9d3b2dd1015 |
| Results XBRL (BSE) | 2020-12-31 | Consolidated | 2021-02-08T18:22:40 | Main_Ind_As_500420_822021182046.xml | 9b2094aa85025e57 |
| Results XBRL (BSE) | 2020-12-31 | Standalone | 2021-02-08T18:22:40 | Main_Ind_As_500420_822021182221.xml | de12e30488f65427 |
| Results XBRL (BSE) | 2021-03-31 | Consolidated | 2021-05-18T17:30:33 | Main_Ind_As_500420_1852021172814.xml | b2339ec62dfb107a |
| Results XBRL (BSE) | 2021-03-31 | Standalone | 2021-05-18T17:30:33 | Main_Ind_As_500420_1852021172946.xml | ff31d978f061e81f |
| Results XBRL (BSE) | 2021-06-30 | Standalone | 2021-07-27T18:05:02 | Main_Ind_As_500420_277202118450.xml | 7c99d17425e82a51 |
| Results XBRL (BSE) | 2021-06-30 | Consolidated | 2021-07-27T18:05:02 | Main_Ind_As_500420_27720211868.xml | ec059a0aef68b2e1 |
| Results XBRL (BSE) | 2021-09-30 | Standalone | 2021-10-27T11:38:26 | Main_Ind_As_500420_27102021113739.xml | d18bd8146b2baff6 |
| Results XBRL (BSE) | 2021-09-30 | Consolidated | 2021-10-27T11:38:26 | Main_Ind_As_500420_27102021114241.xml | f7a361e675679af3 |
| Results XBRL (BSE) | 2021-12-31 | Standalone | 2022-01-25T18:39:27 | Main_Ind_As_500420_251202218394.xml | 24b1ce0889f2012f |
| Results XBRL (BSE) | 2021-12-31 | Consolidated | 2022-01-25T18:39:27 | Main_Ind_As_500420_2512022184029.xml | a2d550531519395a |
| Results XBRL (BSE) | 2022-03-31 | Consolidated | 2022-05-26T10:11:07 | Main_Ind_As_500420_2552022201216.xml | c8efbb1671b5d3eb |
| Results XBRL (BSE) | 2022-03-31 | Standalone | 2022-05-26T10:11:07 | Main_Ind_As_500420_255202220141.xml | 07ee1f4c51a9b0e9 |
| Results XBRL (BSE) | 2022-06-30 | Standalone | 2022-07-30T12:51:09 | Main_Ind_As_500420_297202220049.xml | 320a7ab6c7e2887b |
| Results XBRL (BSE) | 2022-06-30 | Consolidated | 2022-07-30T12:51:09 | Main_Ind_As_500420_29720222023.xml | b12b0a03263d49e8 |
| Results XBRL (BSE) | 2022-09-30 | Consolidated | 2022-10-21T20:39:45 | Main_Ind_As_500420_21102022203559.xml | f017652d8bed2986 |
| Results XBRL (BSE) | 2022-09-30 | Standalone | 2022-10-24T15:39:14 | Main_Ind_As_500420_21102022203854.xml | eae8011c95c88e92 |
| Annual report | 2016-03-31 | grade A | 2016-08-22T00:00:00 | 5004200316.pdf | d3eaca4c8bb5b80f |
| Annual report | 2017-03-31 | grade A | 2017-08-10T00:00:00 | 5004200317.pdf | c25f9e8847d1aa09 |
| Annual report | 2018-03-31 | grade A | 2018-08-08T00:00:00 | 5004200318.pdf | 0694c2e79827477b |
| Annual report | 2019-03-31 | grade A | 2019-06-23T00:00:00 | 5004200319.pdf | 008f0971b0d41fb9 |
| Annual report | 2020-03-31 | grade A | 2020-07-04T00:00:00 | 5004200320.pdf | 8fba7af293525bd6 |
| Annual report | 2021-03-31 | grade A | 2021-07-02T00:00:00 | 68720500420.pdf | 71f3cac0fd7488c7 |
| Annual report | 2022-03-31 | grade A | 2022-07-04T00:00:00 | 73450500420.pdf | 796629037fb9f7ed |
| Annual report | 2023-03-31 | grade A | 2023-07-14T16:50:52.69 | 6fe845d6-918b-4ab8-9efd-36588666eeed.pdf | e15689fe66d71816 |
| Annual report | 2024-03-31 | grade A | 2024-06-29T19:31:29.53 | bf33b4fb-38ba-401a-85c7-58c0a36fed92.pdf | 3d6f64eec9187535 |
| Annual report | 2025-03-31 | grade A | 2025-07-04T17:47:28.85 | 72f4c6a4-acaf-4542-9ee0-563a58f66ed3.pdf | e47227253df83859 |
| Annual report | 2026-03-31 | grade A | 2026-06-01T14:28:57.52 | ff8314b3-63f3-4741-871f-83b50a44e1d9.pdf | 1b038e351e4aa2f1 |
| Concall | 2022-03-31 | COVER_LETTER | — | Date_20220530_Torrent Pharmaceuticals Ltd._Concal_Q4FY22.pdf | 9c32046fd52c85e2 |
| Concall | 2022-06-30 | COVER_LETTER | — | Date_20220805_Torrent Pharmaceuticals Ltd._Concal_Q1FY23.pdf | 1a71dc7c10a203ef |
| Concall | 2022-09-30 | COVER_LETTER | — | Date_20221028_Torrent Pharmaceuticals Ltd._Concal_Q2FY23.pdf | 007b42cc2ae47908 |
| Concall | 2022-12-31 | COVER_LETTER | — | Date_20230201_Torrent Pharmaceuticals Ltd._Concal_Q3FY23.pdf | 07b165df530a5337 |
| Concall | 2023-03-31 | COVER_LETTER | — | Date_20230603_Torrent Pharmaceuticals Ltd._Concal_Q4FY23.pdf | 806d899eeedb42ef |
| Concall | 2023-06-30 | COVER_LETTER | — | Date_20230811_Torrent Pharmaceuticals Ltd._Concal_Q1FY24.pdf | b004f890434eee37 |
| Concall | 2023-09-30 | COVER_LETTER | — | Date_20231026_Torrent Pharmaceuticals Ltd._Concal_Q2FY24.pdf | a1ec8d76b07707b5 |
| Concall | 2023-12-31 | COVER_LETTER | — | Date_20240207_Torrent Pharmaceuticals Ltd._Concal_Q3FY24.pdf | 2fba64b8bbdc443b |
| Concall | 2024-03-31 | COVER_LETTER | — | Date_20240530_Torrent Pharmaceuticals Ltd._Concal_Q4FY24.pdf | b081ed83feb18ed6 |
| Concall | 2024-06-30 | TRANSCRIPT | — | Date_20240729_Torrent Pharmaceuticals Ltd._Concal_Q1FY25.pdf | 2540e618fd4fbd5f |
| Concall | 2024-06-30 | COVER_LETTER | — | Date_20240729_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | d8453c7185b7716f |
| Concall | 2024-09-30 | TRANSCRIPT | — | Date_20241030_Torrent Pharmaceuticals Ltd._Concal_Q2FY25.pdf | b12aac64cb9e8e03 |
| Concall | 2024-09-30 | COVER_LETTER | — | Date_20241030_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | 8c1cc0b11905b356 |
| Concall | 2024-12-31 | COVER_LETTER | — | Date_20250131_Torrent Pharmaceuticals Ltd._Concal_Q3FY25.pdf | f9ad06ca96440519 |
| Concall | 2025-03-31 | COVER_LETTER | — | Date_20250523_Torrent Pharmaceuticals Ltd._Concal_Q4FY25.pdf | 0c28737f7227a556 |
| Concall | 2025-06-30 | TRANSCRIPT | — | Date_20250731_Torrent Pharmaceuticals Ltd._Concal_Q1FY26.pdf | c8b839d82c3aad8b |
| Concall | 2025-06-30 | COVER_LETTER | — | Date_20250731_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | 0a48fab620339e22 |
| Concall | 2025-09-30 | TRANSCRIPT | — | Date_20251113_Torrent Pharmaceuticals Ltd._Concal_Q2FY26.pdf | 349a7ab035fb30da |
| Concall | 2025-09-30 | COVER_LETTER | — | Date_20251113_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | b0eef1f73e4fdba6 |
| Concall | 2025-12-31 | COVER_LETTER | — | Date_20260220_Torrent Pharmaceuticals Ltd._Concal_Q3FY26.pdf | 8d5d7c86f16ed1f5 |
| Concall | 2026-03-31 | TRANSCRIPT | — | Date_20260527_Torrent Pharmaceuticals Ltd._Concal_Q4FY26.pdf | d9f918c836b17dc9 |
| Concall | 2026-03-31 | COVER_LETTER | — | Date_20260527_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | 1bf7471978eabf25 |
| Concall | 2026-06-30 | TRANSCRIPT | — | Date_20260804_Torrent Pharmaceuticals Ltd._Concal_Q1FY27.pdf | 8e7d756a5560c9d3 |
| Concall | 2026-06-30 | COVER_LETTER | — | Date_20260804_Torrent Pharmaceuticals Ltd._Notice_Notice.pdf | 0763f9415226f59c |
| Shareholding XBRL | 2021-09-30 | — | — | SHP_161757_531783_13102021050604_WEB.xml | bf6c56b45548bdd3 |
| Shareholding XBRL | 2021-12-31 | — | — | SHP_164390_586038_13012022015914_WEB.xml | 19403cbb31cdef39 |
| Shareholding XBRL | 2022-03-31 | — | — | SHP_166880_634655_13042022081848_WEB.xml | 8ca39a09972c58b3 |
| Shareholding XBRL | 2022-06-30 | — | — | SHP_169191_686742_13072022123716_WEB.xml | c0a042232dc378b8 |
| Shareholding XBRL | 2022-07-13 | — | — | SHP_169320_688090_13072022091522_WEB.xml | ad5d7b0237eb469f |
| Shareholding XBRL | 2022-09-30 | — | — | SHP_171117_725467_13102022082802_WEB.xml | e1f10e09dbdf5948 |
| Shareholding XBRL | 2022-12-31 | — | — | SHP_174208_766204_13012023053726_WEB.xml | 76d0b0e4df421e80 |
| Shareholding XBRL | 2023-03-31 | — | — | SHP_176990_822383_17042023073521_WEB.xml | 59c2511e6dfa16b6 |
| Shareholding XBRL | 2023-06-30 | — | — | SHP_179392_889667_18072023012856_WEB.xml | dd0e7b82ff709256 |
| Shareholding XBRL | 2023-09-30 | — | — | SHP_180837_944277_09102023070559_WEB.xml | 917847ee78d5dc52 |
| Shareholding XBRL | 2023-12-31 | — | — | SHP_183973_1018211_12012024025402_WEB.xm | 58812638cb28b877 |
| Shareholding XBRL | 2024-03-31 | — | — | SHP_188025_1102768_19042024084244_WEB.xm | 5743e194e7da2e65 |
| Shareholding XBRL | 2024-06-30 | — | — | SHP_189289_1182688_12072024052256_WEB.xm | 50cbb02ddbad6285 |
| Shareholding XBRL | 2024-09-30 | — | — | SHP_191721_1266867_11102024065135_WEB.xm | 6505eff29e257d58 |
| Shareholding XBRL | 2024-12-31 | — | — | SHP_194895_1347516_16012025042708_WEB.xm | a8ac43f9f720ca03 |
| Shareholding XBRL | 2025-03-31 | — | — | SHP_198233_1419252_18042025072033_WEB.xm | bda8a9a50a12e3b2 |
| Shareholding XBRL | 2025-06-30 | — | — | SHP_1488083_19072025090817_WEB.xml | b46177b5681ba7b2 |
| Shareholding XBRL | 2025-09-30 | — | — | SHP_1546746_13102025073956_WEB.xml | 57551bdc22b624c3 |
| Shareholding XBRL | 2025-12-31 | — | — | SHP_1594668_03012026011705_WEB.xml | 0d6d9abaf5ae2f16 |
| Shareholding XBRL | 2026-03-31 | — | — | SHP_1653365_17042026052714_WEB.xml | 5dcc1e7619a9c5aa |
| Shareholding XBRL | 2026-06-30 | — | — | SHP_1697244_20072026060641_WEB.xml | fdf1e6042d2112ea |
| Shareholding XBRL | 2026-07-20 | — | — | SHP_1697348_20072026063703_WEB.xml | 9c2ae884ab3f96e4 |
| Related-party XBRL | 2023-03-31 | — | — | RPT_858477_30052023060958_WEB.xml | c25441abbe50b883 |
| Related-party XBRL | 2023-09-30 | — | — | RPT_966467_23102023063644_WEB.xml | 8881f33ea62a58f1 |
| Related-party XBRL | 2024-03-31 | — | — | RPT_1137999_24052024065527_WEB.xml | 2880f75a2042c588 |
| Related-party XBRL | 2024-09-30 | — | — | RPT_1288705_25102024053155_WEB.xml | 2031e41ccc524b16 |